Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Adastra Labs Holdings Ltd. ( (TSE:XTRX) ) just unveiled an update.
Adastra Holdings Ltd. has announced the appointment of Mark Qvist to its board of directors, effective February 28, 2025. Mr. Qvist brings over 25 years of experience in geotechnical, environmental, and botanical sectors, currently serving as CEO of Life Cycle Botanics Ltd. His diverse background in business operations and regulated industries is expected to positively impact Adastra’s continued success. This strategic appointment follows the resignation of Andrew Hale from the board, as announced earlier.
More about Adastra Labs Holdings Ltd.
Adastra Holdings Ltd. is a prominent Canadian company specializing in the supply and manufacturing of ethnobotanical and cannabis products for adult-use and medical markets. The company is known for its Phyto Extractions and Endgame Extracts brands, which are distributed through over 2,000 retail locations across Canada. Adastra operates a Health Canada licensed facility focusing on extraction, distillation, and manufacturing of cannabis-derived products, partnering with healthcare professionals to address medical cannabis needs.
YTD Price Performance: -5.56%
Average Trading Volume: 2,811
Technical Sentiment Consensus Rating: Buy
Current Market Cap: C$1.9M
For a thorough assessment of XTRX stock, go to TipRanks’ Stock Analysis page.